Expected earnings - Virax Biolabs Group Limited
Source: US Earnings Reports
Virax Biolabs Group Limited (VRAX) is expected to report $-0.34 for Q1 2026
Virax Biolabs Group Limited
NASDAQ: VRAX
VRAX Trading
5.1% G/L:
$0.235 Last:
68,143 Volume:
$0.2166 Open:
VRAX Latest News
December 04, 2025 04:05:00 pm
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
December 03, 2025 07:34:00 am
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
VRAX Stock Data
$1,720,009
6,703,359
N/A
1
N/A
Medical Diagnostics & Screening
Healthcare
GB
Lanarkshire
